摘要
以甲壳素为原料,采用低温羧甲基化反应制备C6位取代羧甲基甲壳素(6-O-CMCH),然后脱去C2位乙酰基得到C6位取代羧甲基壳聚糖(6-O-CMCS),最后将6-O-CMCS与氯磺酸-浓硫酸反应,通过控制反应条件,获得了取代位置和取代度部分可控的硫酸酯化6-O-CMCS。利用电位滴定、元素分析、FT-IR、1 H-NMR测试分析各级产物的化学结构,并测定终产物活化部分的凝血活酶时间(APTT)、血浆凝血酶原时间(PT)及血浆凝血酶时间(TT)。实验结果表明:硫酸酯化6-O-CMCS与高分子量肝素的结构和抗凝血活性类似,其抗凝血活性机理主要体现在对内源性和共同凝血途径的抑制。
6-O-carboxymethyl chitin (6-O-CMCH) was prepared from chitin at low temperature, and then 6-O-CMCH was deacetylated to obtain 6-O-carboxymethyl chitosan (6-O-CMCS). The sulfated 6-O-CMCS with limited controllable substitution was prepared by a controlled reaction between 6-O-CMCS and chlorosulfonic acid/concentrated sulfuric acid. 6-O-CMCH and sulfated 6-O-CMCS were characterized with conductometric titration, elemental analysis, FT-IR, and 1H-NMR methods. The sulfated 6-O-CMCS was measured to determine its activated partial thromboplastin time (APTT), prothrombin time (PT) and thrombin time (TT). Results indicated that the structure and blood anticoagulation of sulfated 6-O-CMCS were similar to that of heparin, and its activity of blood anticoagulation was mainly due to the suppression of endogenous and common coagulation pathway.
出处
《功能高分子学报》
CAS
CSCD
北大核心
2015年第2期201-206,共6页
Journal of Functional Polymers
基金
深圳市战略性新兴产业发展专项资金项目(YCYJ20120613170845998)